The report covers forecast and analysis for the drug discovery informatics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD million). The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the drug discovery informatics market on a global level.
In order to give the users of this report a comprehensive view on the drug discovery informatics market, we have included a detailed competitive scenario and model portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the drug discovery informatics market has also been included. The study encompasses a market attractiveness analysis, wherein type segments are benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view on the drug discovery informatics market by segmenting the market based on mode, services, and region. Based on mode, the drug discovery informatics market can be segmented into outsourced informatics and in-house informatics. The major services covered under this study include docking and modular modeling. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, New Zealand, Egypt, Argentina and Brazil.
The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. The key players of ChemAxon, GVK Biosciences, Jubilant Biosys, Selvita, Certara, Infosys, Albany Molecular Research Inc., Boehringer Ingelheim GmBh, DiscoverX, Charles River Laboratories, Covance, Collaborative Drug Discovery Inc., Novo Informatics, UCB, Evotec among others.
This report segments the drug discovery informatics market as follows:
Drug Discovery Informatics Market: Mode Segment Analysis
- Outsourced Informatics
- In-House Informatics
Drug Discovery Informatics Market: Services Segment Analysis
- Docking
- Modular Modeling
Drug Discovery Informatics Market: Regional Segment Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- The Middle East and Africa
- South Africa
- Egypt
